Aclaris Therapeutics (ACRS) Stock Chart & Stock Price History $1.80 +0.05 (+2.86%) Closing price 08/22/2025 04:00 PM EasternExtended Trading$1.82 +0.01 (+0.83%) As of 08/22/2025 06:29 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Aclaris Therapeutics Stock Price Performance The Aclaris Therapeutics (ACRS) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 48.76%, with a year-to-date return of -27.42%. In the past month, the stock has increased 7.14%, reflecting recent market activity. As of the latest close, Aclaris Therapeutics traded at $1.80 with a market cap of $195.00 million and volume of 577,571 shares. Receive ACRS Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Aclaris Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+0.56%1 Month Performance+7.14%3 Month Performance+42.86%Year-To-Date Performance-27.42%1 Year Performance+48.76% ACRS Stock Chart for Sunday, August, 24, 2025 ACRS Chart by TradingView Aclaris Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/22/2025$1.75$1.80+2.86%$1.83$1.76577,571 shs$195.00 million08/21/2025$1.81$1.75-3.31%$1.82$1.75260,116 shs$189.58 million08/20/2025$1.79$1.81+1.12%$1.84$1.77513,158 shs$196.08 million08/19/2025$1.85$1.79-3.24%$1.85$1.75995,478 shs$193.91 million08/18/2025$1.87$1.85-1.07%$1.92$1.811.14 million shs$200.41 million08/15/2025$1.69$1.87+10.65%$1.90$1.701.61 million shs$202.58 million08/14/2025$1.70$1.69-0.59%$1.75$1.67448,103 shs$183.08 million08/13/2025$1.64$1.70+3.66%$1.77$1.631.59 million shs$184.16 million08/12/2025$1.64$1.64$1.65$1.58559,439 shs$177.66 million08/11/2025$1.63$1.64+0.61%$1.67$1.601.10 million shs$177.66 million Get the Latest News and Ratings for ACRS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Aclaris Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 08/08/2025$1.57$1.63+3.82%$1.65$1.57779,761 shs$176.50 million08/07/2025$1.55$1.57+1.29%$1.58$1.52608,330 shs$170 million08/06/2025$1.55$1.55$1.58$1.52716,019 shs$167.84 million08/05/2025$1.56$1.55-0.64%$1.60$1.53415,584 shs$167.83 million08/04/2025$1.53$1.56+1.96%$1.56$1.50663,275 shs$168.92 million08/01/2025$1.53$1.53$1.59$1.501.09 million shs$165.67 million07/31/2025$1.53$1.53$1.56$1.461.27 million shs$165.67 million07/30/2025$1.55$1.53-1.29%$1.86$1.506.33 million shs$165.67 million07/29/2025$1.68$1.55-7.74%$1.71$1.546.67 million shs$167.83 million07/28/2025$1.70$1.68-1.18%$1.76$1.64840,814 shs$181.91 million07/25/2025$1.68$1.70+1.19%$1.72$1.67441,182 shs$184.08 million07/24/2025$1.68$1.68$1.78$1.641.38 million shs$181.91 million07/23/2025$1.62$1.68+3.70%$1.68$1.62345,746 shs$181.91 million Related Companies Nurix Therapeutics Stock Chart Niagen Bioscience Stock Chart Pharming Group Stock Chart ArriVent BioPharma Stock Chart Sana Biotechnology Stock Chart Gyre Therapeutics Stock Chart Oculis Stock Chart Ginkgo Bioworks Stock Chart atai Life Sciences Stock Chart Immatics Stock Chart Receive ACRS Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Aclaris Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:ACRS) was last updated on 8/24/2025 by MarketBeat.com Staff From Our PartnersTrump’s betrayal exposedTrump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredTrump’s “new dollar” could shock Americans"I Made Millions in the Tech Boom. Here's Where I'd Put My Money Today" This man has called some of the big...Stansberry Research | SponsoredHere's the last trade you should make before heading out for the weekend tomorrow.On a quiet Friday afternoon, one trader spotted an overlooked stock. He bought shares. He shut down his ...Timothy Sykes | SponsoredTrump’s SHOCKING Plan to Create MASSIVE Wealth for AmericansJames Altucher says Donald Trump just made a move so surprising, it could go down as the most lucrative presid...Paradigm Press | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aclaris Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aclaris Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access